BIOVIT, Contact Infection Prevention Effective Cosmetic Material Registered to INCI


2021-01-19

With the COVID-19 crisis continuing for longer and without any hint of stopping, cosmetic market has also been shifting along with the current atmosphere.

As wearing masks have become normalized in the consumer lifestyle, beauty trend has also changed. People are preferring eye makeup

over lip makeup, and powderless makeup over foundations.

Specifically, the most noticeable cosmetic trend happens to be beauty relating to health. This became a natural occurrence as health has become

a growing concern during the COVID-19 crisis, and more of the population are committing to at-home work. Beauty in cosmetics has simply

been outranked by basic skin care in the cosmetic market.

BIOVIT, known for its Peptide Stabilization Platform (PSP) technology, has announced that its new ECM antimicrobial protein material has

successfully been registered in International Nomenclature of Cosmetic Ingredients (INCI). The registered material has shown effectiveness

against contact-based infection and skin troubles.

ECM antimicrobial protein is human-derived peptides that selectively kills Staphylococcus, Ance bacteria and other pathogens while not

impacting human cells, showing safety in its use. For even stronger confirmations, BIOVIT has completed efficacy tests through

Research & Development Centers and shown no harmful effects with the peptides through Human Body Application Tests showing negative

on irritations.

BIOVIT representative notes that “ECM antimicrobial protein developed and tested hundreds of trials in BIOVIT laboratory have given us with

great anticipation that it will effectively solve skin troubles and irritations consumers were worried due to long-term mask wearing,” and

“antimicrobial peptides have immune regulation function that intervenes irritative reactions, showing effectiveness on skin irritation issues.”